Published in

Taylor and Francis Group, Journal of Biopharmaceutical Statistics, p. 1-10, 2023

DOI: 10.1080/10543406.2023.2170398

Links

Tools

Export citation

Search in Google Scholar

Assessing adverse events in clinical trials during the era of the COVID-19 pandemic

Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO